Xcout Intel
Emulate, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Emulate, Inc. among biotechnology companies — ranked by similarity to what Emulate, Inc. actually does, not by market-cap band.
Subscribe to see Emulate, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Emulate, Inc.
Emulate, Inc. (Emulate) is a biotechnology company that commercialized Organs-on-Chips technology—a human cell-based technology that recreates organ-level function to model organs in healthy and diseased states. The technology has applications in pharmaceutical research, product development, testing how different medicines, chemicals, and foods affect human health. Emulate has also worked with Cedars-Sinai Medical Center on a precision medicine initiative that uses Organs-on-Chips technology in the clinical setting. This initiative is designed to provide clinicians with better data about how a
Emulate, Inc. at a glance
Emulate, Inc. is a biotechnology company headquartered in United States, founded in 2014. Its most recent funding round raised $57.5M in August 2021. Xcout tracks 10 named people at Emulate, Inc., including Jim Corbett (CEO, Board Member).
Emulate, Inc. leadership
- Jim CorbettCEO, Board Member
- Lorna EwartChief Scientific officer
- Daniel LevnerCo-Founder, CTO
- Donald IngberScientific Founder, Board Member, Scientific Advisory Board Chairman
- Jack Parker-HolderCo-Founder
- Matthew McGillCo-Founder
4 more named people on record for Emulate, Inc., with roles, board committees and tenure — see the full roster →
Emulate, Inc. funding rounds
The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $57.5M | — | |
| Series E | $82M | 5 named | |
| SEC Form D filing | $19.3M | — | |
| SEC Form D filing | $28M | — | |
| SEC Form D filing | $36M | — | |
| SEC Form D filing | $745,750 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Emulate, Inc. news
Top 12 Emulate, Inc. competitors
Ranked by semantic similarity — how close each company is to Emulate, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
BioTech
Mimetas is a privately owned biotechnology company developing human organ-on-a-chip tissue models and products for drug development. The company also is involved in the testing of chemicals along with food and personalized medicine applications. The company is based in Oegstgeest and Enschede, The Netherlands, with subsidiairies in Gaithersburg (MD), United States, and Tokyo, Japan. Mimetas was founded in 2011 by Paul Vulto, Jos Joore, Bas Trietsch and Thomas Hankemeier. The company is co-led by Joore and Vulto as CEOs.
Similar biotechnology company
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
Similar biotechnology company
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Biotech
Hubrecht Organoid Technology (HUB) develops patented patient-derived organoid technology from healthy and diseased tissues to predict patient responses to treatments. The company functions as a contract research organization (CRO), offering drug discovery services, custom model and assay development, clinical trials in a dish, and licensing programs for pharmaceutical and research applications.
Biotech
InSphero provides 3D in vitro cell culture models, microplates, organ-on-a-chip platforms, and related services for drug discovery and safety testing. The company serves pharmaceutical, biotechnology, and research organizations seeking non-animal testing alternatives to evaluate drug efficacy, liver safety, oncology, and other complex diseases.
Biotech
Ginkgo Bioworks Holdings, Inc., alongside its subsidiary entities, provides an advanced technological platform focused on the engineering of cells. This proprietary system is utilized to manipulate cellular functions, facilitating the biological creation of various products. These outputs span from innovative pharmaceutical treatments and vital food components to sustainable chemicals designed to replace those traditionally sourced from petroleum. The enterprise caters to a broad spectrum of industries, encompassing specialized chemical manufacturing, the agricultural sector, food production, consumer goods, and pharmaceuticals. Furthermore, Ginkgo Bioworks has forged a partnership with Selecta Biosciences, Inc., for the joint advancement of the ImmTOR technology platform. The company, founded in 2008, is headquartered in Boston, Massachusetts.
Life Sciences
BiomimX Srl is a biotech company headquartered in Milan, Italy, operating out of the MIND – Milano Innovation District. The company relies on proprietary uBeat technology, a breakthrough actuator patented by Politecnico di Milano, to develop advanced biological models.
Similar biotechnology company
AxoSim Technologies is a privately held biotechnology company founded in 2014 and headquartered in New Orleans, Louisiana. The company develops proprietary NerveSim and BrainSim platforms that provide predictive models of the human nervous system. These technologies are designed to help biopharmaceutical companies deliver human data faster, reduce clinical failures, and accelerate the development of neurological drugs.
Biotech
Emerald Cloud Lab (ECL) is a privately owned biotech startup. The company focuses on advancing laboratory virtualization, for chemistry and biotechnology, by building the first fully functional cloud lab, allowing scientists to conduct all of their wet lab research without being in a physical laboratory.
Similar biotechnology company
Axol Bioscience is a leading provider of iPSC-derived cells and related services, supporting neuroscience, ophthalmology, and cardiotoxicity drug discovery with advanced human disease models.
Similar biotechnology company
Nuclera provides products and services for multiplex protein screening and expression, including the eProtein Discovery system and related reagents, software, and services. The company serves researchers and scientists in drug discovery and biotechnology by enabling them to perform in-house protein design, screening, characterization, and small-scale expression.
Similar biotechnology company
StemoniX, Inc. was a for-profit biotechnology company with its headquarters located in Maple Grove, Minnesota. The firm developed innovative human cellular models and microfluidic technologies for drug discovery and toxicity testing.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Emulate, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Emulate, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →